SpotLight

With rise of gene therapy and other innovative therapeutic approaches, we experience profound change in Netherton syndrome treatment space.

It is not surprising that the healthcare sector is undergoing a significant transition in an era characterized by technological developments and the digitization of almost every aspect of our lives. The development of smart medical devices is a shining illustration of how technology has advanced in healthcare in a ...

Orchard Therapeutics received FDA acceptance for its BLA for OTL-200, a gene therapy in pipeline for metachromatic leukodystrophy treatment.

FDA approved GSK's momelotinib, marketed under name Ojjaara, for management of myelofibrosis in adult patients suffering from anemia.

Sleep Aids Market: Examining Cutting-Edge Technologies and Scientific Breakthroughs Sleep can be burdensome when it disrupts daily routines, requires a significant time commitment, and is marred by sleep disorders or disturbances that affect overall well-being. In today's fast-paced world, where stress, anxiety,...

Huntington’s disease is an incurable, rare genetic, progressive neurodegenerative disorder. According to the National Organization for Rare Disorders (NORD), about 30,000 people in the United States have Huntington’s disease, and another 200,000 are at risk of developing the condition. As per DelveInsight analy...

The dynamics of the myelodysplastic syndrome treatment market are anticipated to change in the coming years owing to the emerging therapies.

Biosurgery products demand is rising, fueled by the need for innovative surgical solutions and also propelling the market growth.

Chronic pain is an unwelcome companion in the journey of life and can significantly impact the quality of life. Being in pain serves as a protective mechanism that warns us when something is wrong with the concerned body part, and is a natural component of the human experience. But for millions of people around the...

As per Delveinsight, the Fabry disease treatment market is likely boost enormous contribution from conventional enzyme replacement therapies.